These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9871744)

  • 1. 1,2-disubstituted cyclohexane derived tripeptide aldehydes as novel selective thrombin inhibitors.
    Harmat NJ; Di Bugno C; Criscuoli M; Giorgi R; Lippi A; Martinelli A; Monti S; Subissi A
    Bioorg Med Chem Lett; 1998 May; 8(10):1249-54. PubMed ID: 9871744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptide-derived transition state analogue inhibitors of thrombin; synthesis, activity and selectivity.
    Jetten M; Peters CA; Visser A; Grootenhuis PD; van Nispen JW; Ottenheijm HC
    Bioorg Med Chem; 1995 Aug; 3(8):1099-114. PubMed ID: 7582983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amide and alpha-keto carbonyl inhibitors of thrombin based on arginine and lysine: synthesis, stability and biological characterization.
    Brady SF; Sisko JT; Stauffer KJ; Colton CD; Qiu H; Lewis SD; Ng AS; Shafer JA; Bogusky MJ; Veber DF
    Bioorg Med Chem; 1995 Aug; 3(8):1063-78. PubMed ID: 7582980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New tripeptidic thrombin inhibitors. Influence of P2 and P3 residues on activity and selectivity.
    De Nanteuil G; Gloanec P; Lila C; Portevin B; Boudon A; Rupin A; Verbeuren TJ
    Bioorg Med Chem; 1995 Aug; 3(8):1019-24. PubMed ID: 7582976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystallographic structure of a peptidyl keto acid inhibitor and human alpha-thrombin.
    Håkansson K; Tulinsky A; Abelman MM; Miller TA; Vlasuk GP; Bergum PW; Lim-Wilby MS; Brunck TK
    Bioorg Med Chem; 1995 Aug; 3(8):1009-17. PubMed ID: 7582975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly selective tripeptide thrombin inhibitors.
    Shuman RT; Rothenberger RB; Campbell CS; Smith GF; Gifford-Moore DS; Gesellchen PD
    J Med Chem; 1993 Feb; 36(3):314-9. PubMed ID: 8426361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic selective inhibitors of thrombin.
    Okamoto S; Hijikata-Okunomiya A
    Methods Enzymol; 1993; 222():328-40. PubMed ID: 8412802
    [No Abstract]   [Full Text] [Related]  

  • 8. Thrombin inhibitors based on ketone derivatives of arginine and lysine.
    Jones DM; Atrash B; Ryder H; Teger-Nilsson AC; Gyzander E; Szelke M
    J Enzyme Inhib; 1995; 9(1):43-60. PubMed ID: 8568566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and comparison of tripeptidylfluoroalkane thrombin inhibitors.
    Neises B; Broersma RJ; Tarnus C; Piriou F; Remy JM; Lintz C; Heminger EF; Kutcher LW
    Bioorg Med Chem; 1995 Aug; 3(8):1049-61. PubMed ID: 7582979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity study of tripeptide thrombin inhibitors using alpha-alkyl amino acids and other conformationally constrained amino acid substitutions.
    Shuman RT; Rothenberger RB; Campbell CS; Smith GF; Gifford-Moore DS; Paschal JW; Gesellchen PD
    J Med Chem; 1995 Oct; 38(22):4446-53. PubMed ID: 7473571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Active site-directed thrombin inhibitors: alpha-hydroxyacyl-prolyl-arginals. New orally active stable analogs of D-Phe-Pro-Arg-H.
    Bajusz S; Barabás E; Fauszt I; Fehér A; Horváth G; Juhász A; Szabó AG; Széll E
    Bioorg Med Chem; 1995 Aug; 3(8):1079-89. PubMed ID: 7582981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and structure-activity relationship of thrombin inhibitors with an azaphenylalanine scaffold: potency and selectivity enhancements via P2 optimization.
    Zega A; Mlinsek G; Sepic P; Golic Grdadolnik S; Solmajer T; Tschopp TB; Steiner B; Kikelj D; Urleb U
    Bioorg Med Chem; 2001 Oct; 9(10):2745-56. PubMed ID: 11557360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular modeling and 3D-QSAR studies on the interaction mechanism of tripeptidyl thrombin inhibitors with human alpha-thrombin.
    Jiang H; Chen K; Tang Y; Chen J; Li Q; Wang Q; Ji R
    J Med Chem; 1997 Sep; 40(19):3085-90. PubMed ID: 9301672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active site-directed thrombin inhibitors--II. Studies related to arginine/guanidine bioisosteres.
    St Laurent DR; Balasubramanian N; Han WT; Trehan A; Federici ME; Meanwell NA; Wright JJ; Seiler SM
    Bioorg Med Chem; 1995 Aug; 3(8):1145-56. PubMed ID: 7582986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular modeling studies of novel retro-binding tripeptide active-site inhibitors of thrombin.
    Lau WF; Tabernero L; Sack JS; Iwanowicz EJ
    Bioorg Med Chem; 1995 Aug; 3(8):1039-48. PubMed ID: 7582978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclotheonamide derivatives: synthesis and thrombin inhibition. Exploration of specific structure-function issues.
    Maryanoff BE; Zhang HC; Greco MN; Glover KA; Kauffman JA; Andrade-Gordon P
    Bioorg Med Chem; 1995 Aug; 3(8):1025-38. PubMed ID: 7582977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of novel thrombin inhibitors. Use of ring-closing metathesis reactions for synthesis of P2 cyclopentene- and cyclohexenedicarboxylic acid derivatives.
    Thorstensson F; Kvarnström I; Musil D; Nilsson I; Samuelsson B
    J Med Chem; 2003 Mar; 46(7):1165-79. PubMed ID: 12646027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-depth study of tripeptide-based alpha-ketoheterocycles as inhibitors of thrombin. Effective utilization of the S1' subsite and its implications to structure-based drug design.
    Costanzo MJ; Almond HR; Hecker LR; Schott MR; Yabut SC; Zhang HC; Andrade-Gordon P; Corcoran TW; Giardino EC; Kauffman JA; Lewis JM; de Garavilla L; Haertlein BJ; Maryanoff BE
    J Med Chem; 2005 Mar; 48(6):1984-2008. PubMed ID: 15771442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular recognition at the thrombin active site: structure-based design and synthesis of potent and selective thrombin inhibitors and the X-ray crystal structures of two thrombin-inhibitor complexes.
    Obst U; Banner DW; Weber L; Diederich F
    Chem Biol; 1997 Apr; 4(4):287-95. PubMed ID: 9195869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Active site-directed synthetic thrombin inhibitors: synthesis, in vitro and in vivo activity profile of BMY 44621 and analogs. An examination of the role of the amino group in the D-Phe-Pro-Arg-H series.
    Balasubramanian N; St Laurent DR; Federici ME; Meanwell NA; Wright JJ; Schumacher WA; Seiler SM
    J Med Chem; 1993 Jan; 36(2):300-3. PubMed ID: 8423602
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.